MS Views and News Be empowered with MS views and news. To receive The MS BEACON e-Newsletter, CLICK HERE - -

Visit our MS learning channel on YouTube, which provides hundreds of MS educational videos presented by MS Experts from across the USA. Archived here: -- Also please visit our Social media platforms: Facebook, Twitter, and Instagram . Each providing important information for the MS community. Furthermore, scroll down the left side of this blog to learn from the resources and links.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.


Thursday, March 9, 2017

MS Researchers Look at Medical Marijuana for Neuropathic Pain

Click here to receive MS news via e-mail

A Canadian research group is looking at the use of cannabis oil as a treatment for neuropathic pain in multiple sclerosis patients.
Medical marijuana now available in controlled-dose capsules in New York. Read more here. 

Using mice models, the study is investigating the pain relief properties of two types of cannabinoid oil produced by CanniMed Therapeutics specifically for chronic pain associated with multiple sclerosis. The researchers are using CanniMed 10:10 which contains equal measures of CBD (cannabidiol) and THC (tetrahydrocannabinol) and the company’s CanniMed 1:20 which only contains CBD.
The study aims to discover how effective the medical marijuana is at treating MS-associated pain and also to discover the molecular effects of the oils and exactly how it works as a pain relief treatment. Find out more about this study here.  

MS Views and News is MAKING an IMPACT on those affected by Multiple Sclerosis

No comments: